Fig. 4From: Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patientsOverall survival rate of autoimmune hepatitis patients with or without hepatocellular carcinoma. In the group without HCC, the median survival time (MST) was not achieved and the 1-year and 5-year survival rates were 96.2% and 94.7%, respectively. In the group with HCC, the MST was 7.5 years, and the 1-year and 5-year survival rates were 100% and 70.0%, respectively. HCC, hepatocellular carcinomaBack to article page